172 related articles for article (PubMed ID: 34240451)
1. Efficacy and safety of oral sirolimus for high-flow vascular malformations in real clinical practice.
Durán-Romero AJ; Hernández-Rodríguez JC; Ortiz-Álvarez J; Domínguez-Cruz JJ; Monserrat-García MT; Conejo-Mir Sánchez J; Bernabeu-Wittel J
Clin Exp Dermatol; 2022 Jan; 47(1):57-62. PubMed ID: 34240451
[TBL] [Abstract][Full Text] [Related]
2. Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II study.
Hammer J; Seront E; Duez S; Dupont S; Van Damme A; Schmitz S; Hoyoux C; Chopinet C; Clapuyt P; Hammer F; Vikkula M; Boon LM
Orphanet J Rare Dis; 2018 Oct; 13(1):191. PubMed ID: 30373605
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of sirolimus in the treatment of vascular anomalies: A systematic review.
Freixo C; Ferreira V; Martins J; Almeida R; Caldeira D; Rosa M; Costa J; Ferreira J
J Vasc Surg; 2020 Jan; 71(1):318-327. PubMed ID: 31676179
[TBL] [Abstract][Full Text] [Related]
4. Single Center Experience of Sirolimus Therapy in Head and Neck Low-flow Vascular Malformations.
Pang C; Evans N; Jethwa P; Papadopoulou A; Khalifa M; Tsui J; Hamilton G; Lim CS; Brookes J
Vasc Endovascular Surg; 2021 Jul; 55(5):482-490. PubMed ID: 33878964
[TBL] [Abstract][Full Text] [Related]
5. Treatment of voluminous and complicated superficial slow-flow vascular malformations with sirolimus (PERFORMUS): protocol for a multicenter phase 2 trial with a randomized observational-phase design.
Maruani A; Boccara O; Bessis D; Guibaud L; Vabres P; Mazereeuw-Hautier J; Barbarot S; Chiaverini C; Blaise S; Droitcourt C; Mallet S; Martin L; Lorette G; Woillard JB; Jonville-Bera AP; Rollin J; Gruel Y; Herbreteau D; Goga D; le Touze A; Leducq S; Gissot V; Morel B; Tavernier E; Giraudeau B;
Trials; 2018 Jun; 19(1):340. PubMed ID: 29945674
[TBL] [Abstract][Full Text] [Related]
6. Oral rapamycin: an alternative in children with complicated vascular abnormalities.
Gómez Sánchez A; Redondo Sedano JV; Pérez Alonso V; Martí Carrera ME; Baro Fernández M; Palencia Pérez SI; Gallego Herrero MC; Gómez Fraile A; Delgado Muñoz MD
Cir Pediatr; 2020 Oct; 33(4):183-187. PubMed ID: 33016658
[TBL] [Abstract][Full Text] [Related]
7. Sirolimus (Rapamycin) for Slow-Flow Malformations in Children: The Observational-Phase Randomized Clinical PERFORMUS Trial.
Maruani A; Tavernier E; Boccara O; Mazereeuw-Hautier J; Leducq S; Bessis D; Guibaud L; Vabres P; Carmignac V; Mallet S; Barbarot S; Chiaverini C; Droitcourt C; Bursztejn AC; Lengellé C; Woillard JB; Herbreteau D; Le Touze A; Joly A; Léauté-Labrèze C; Powell J; Bourgoin H; Gissot V; Giraudeau B; Morel B
JAMA Dermatol; 2021 Nov; 157(11):1289-1298. PubMed ID: 34524406
[TBL] [Abstract][Full Text] [Related]
8. Oral Sirolimus: An Option in the Management of Neonates with Life-Threatening Upper Airway Lymphatic Malformations.
Triana P; Miguel M; Díaz M; Cabrera M; López Gutiérrez JC
Lymphat Res Biol; 2019 Oct; 17(5):504-511. PubMed ID: 30985248
[No Abstract] [Full Text] [Related]
9. Oral and Topical Sirolimus for Vascular Anomalies: A Multicentre Study and Review.
Sandbank S; Molho-Pessach V; Farkas A; Barzilai A; Greenberger S
Acta Derm Venereol; 2019 Oct; 99(11):990-996. PubMed ID: 31304557
[TBL] [Abstract][Full Text] [Related]
10. Sirolimus in the Treatment of Vascular Anomalies.
Triana P; Dore M; Cerezo VN; Cervantes M; Sánchez AV; Ferrero MM; González MD; Lopez-Gutierrez JC
Eur J Pediatr Surg; 2017 Feb; 27(1):86-90. PubMed ID: 27723921
[No Abstract] [Full Text] [Related]
11. Patients with Congenital Low-Flow Vascular Malformation Treated with Low Dose Sirolimus.
Harbers VEM; Rongen GAPJM; van der Vleuten CJM; Verhoeven BH; de Laat PCJ; van der Horst CMAM; Klein WM; Schultze Kool LJ; Loo DMWMT
Adv Ther; 2021 Jun; 38(6):3465-3482. PubMed ID: 34003452
[TBL] [Abstract][Full Text] [Related]
12. Treatment of superficial vascular anomalies with topical sirolimus: A multicenter case series.
Dodds M; Tollefson M; Castelo-Soccio L; Garzon MC; Hogeling M; Hook K; Boull C; Maguiness S
Pediatr Dermatol; 2020 Mar; 37(2):272-277. PubMed ID: 31957126
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies.
Adams DM; Trenor CC; Hammill AM; Vinks AA; Patel MN; Chaudry G; Wentzel MS; Mobberley-Schuman PS; Campbell LM; Brookbank C; Gupta A; Chute C; Eile J; McKenna J; Merrow AC; Fei L; Hornung L; Seid M; Dasgupta AR; Dickie BH; Elluru RG; Lucky AW; Weiss B; Azizkhan RG
Pediatrics; 2016 Feb; 137(2):e20153257. PubMed ID: 26783326
[TBL] [Abstract][Full Text] [Related]
14. Sirolimus for the treatment of children with various complicated vascular anomalies.
Lackner H; Karastaneva A; Schwinger W; Benesch M; Sovinz P; Seidel M; Sperl D; Lanz S; Haxhija E; Reiterer F; Sorantin E; Urban CE
Eur J Pediatr; 2015 Dec; 174(12):1579-84. PubMed ID: 26040705
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of sirolimus in the treatment of vascular malformations: A protocol for systematic review and meta-analysis.
Dong J; Han D; Wang D; Lu H; Wang X
Medicine (Baltimore); 2020 Oct; 99(40):e22596. PubMed ID: 33019479
[TBL] [Abstract][Full Text] [Related]
16. Sirolimus treatment for paediatric head and neck lymphatic malformations: a systematic review.
Saibene AM; Rosso C; Felisati G; Pignataro L; Schindler A; Ghilardi G; Colletti G; Gaffuri M; Mozzanica F
Eur Arch Otorhinolaryngol; 2023 Aug; 280(8):3529-3540. PubMed ID: 37115326
[TBL] [Abstract][Full Text] [Related]
17. The impact of sirolimus therapy on lesion size, clinical symptoms, and quality of life of patients with lymphatic anomalies.
Ozeki M; Nozawa A; Yasue S; Endo S; Asada R; Hashimoto H; Fukao T
Orphanet J Rare Dis; 2019 Jun; 14(1):141. PubMed ID: 31196128
[TBL] [Abstract][Full Text] [Related]
18. Treatment with oral or topical sirolimus in complex vascular anomalies in pediatrics. Experience in a third-level hospital.
Fernández Oliveira C; Martínez Roca C; Gómez Tellado M; Salvador Garrido MP; Outeda Macías M; Martín Herranz I
Cir Pediatr; 2023 Apr; 36(2):60-66. PubMed ID: 37093114
[TBL] [Abstract][Full Text] [Related]
19. Single-center experience with sirolimus therapy for vascular malformations.
Yesil S; Tanyildiz HG; Bozkurt C; Cakmakci E; Sahin G
Pediatr Hematol Oncol; 2016 Apr; 33(3):219-25. PubMed ID: 27128161
[TBL] [Abstract][Full Text] [Related]
20. A prospective multicenter study of sirolimus for complicated vascular anomalies.
Ji Y; Chen S; Yang K; Zhou J; Zhang X; Jiang X; Xu X; Lu G; Qiu L; Kong F; Zhang Y
J Vasc Surg; 2021 Nov; 74(5):1673-1681.e3. PubMed ID: 34082006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
